SCHEMBL29528670

SCHEMBL29528670

CN1c2ccccc2N(c2c(-c3ccccc3)c(-c3ccccc3)c(-c3cccc(-c4nc5ccccc5s4)c3)c(-c3ccccc3)c2N2c3ccccc3N(C)c3ccccc32)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.49
RAB9A P51151 7/20 0.49
SMN1; SMN2 Q16637 7/20 0.49
MAPT P10636 6/20 0.49
ALDH1A1 P00352 6/20 0.49
NPC1 O15118 5/20 0.49
NFKB1 P19838 4/20 0.49
NFKB2 Q00653 4/20 0.49
RELA Q04206 4/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
HSD17B10 Q99714 4/20 0.49
TP53 P04637 3/20 0.49
POLB P06746 2/20 0.49
LMNA P02545 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
GAA P10253 2/20 0.45
DUSP3 P51452 1/20 0.43
PTPN5 P54829 1/20 0.43
PTPN11 Q06124 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29528740 0.98 KDM4E (0.49) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528458 0.90 KDM4E (0.52) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528870 0.89 ILK (0.43) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528409 0.88 RAB9A (0.48) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528661 0.88 RAB9A (0.48) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528648 0.88 RAB9A (0.48) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528750 0.88 ILK (0.44) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528682 0.87 ILK (0.43) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29528699 0.85 RAB9A (0.50) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL29529518 0.81 ILK (0.46) KDM4ERAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11283027-B1 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11283027-B1 Composition of matter for use in organic light-emitting diodes ALDH1A2, CYBA, CRY2 KDM4E 4331/4885RAB9A 3307/4885SMN1; SMN2 1687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.